Family Office Briefing on research byTranswestern·Sep 15, 2023
Houston Life Science Research Report - Summer-Fall 2023
Houston life sciences sector sees significant funding growth in 2023 — family offices should consider co-GP opportunities with leading operators.
Key Metrics
| Metric | Value |
|---|---|
| CPRIT Funding | 64.9million |
| Venture Capital Funding | 258.7million |
| NIH Funding | 512.7million |
| Life Sciences Under Construction | 600,000SF |
Metrics extracted from the source report and independently fact-checked. Method →
Full report
Transwestern
Building a thesis around Houston? Share it confidentially with the Thesis Exchange — we pair you anonymously with family offices running adjacent life science strategies.
Peer Network · By Invitation
The Thesis Exchange
Share an investment thesis in confidence. We pair you anonymously with up to two other family offices running adjacent strategies. Reviewed by Gallium's editorial team. No vendor pitch.